LY03020

· Luye Pharma Group Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY03020, covering 2025-05-29 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia [Phase 2]

See pricing